
Erytrust 2000IU Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Recombinant Human Erythropoietin Alfa (2000IU)
Overview Erytrust 2000IU Injection
Epoetin alfa 2000IU injection stimulates red blood cell production in the bone marrow. This medication treats anemia resulting from kidney disease, cancer chemotherapy, or HIV medications. Administered subcutaneously or intravenously as directed by your physician (typically by a healthcare professional), dosage is weight-based and tailored to the anemia's cause. Concurrent iron supplementation can enhance treatment efficacy. Store refrigerated, but allow to reach room temperature before use. Common side effects, often more pronounced initially, include nausea, vomiting, fever, hypertension, and flu-like symptoms (headache, fatigue, dizziness, myalgia). Persistent side effects warrant medical consultation; report serious adverse events, such as seizures, immediately. Serious blood clots are a potential risk requiring prompt medical attention. Inform your doctor of pre-existing conditions, including uncontrolled hypertension, heart disease, or gout, and any concurrent medications. Regular blood pressure monitoring and other tests are necessary to monitor for adverse effects. The effects on pregnancy are unknown; disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Erytrust 2000IU Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Erytrust 2000IU Injection
Managing Anemia in Cancer Chemotherapy Patients | Addressing Anemia Associated with Chronic Kidney Disease
Major Benefits of Erytrust 2000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Erytrust 2000IU Injection:
- High blood pressure
- Nausea
- Vomiting
- Fever
- Rash
- Joint pain
- Headache
- Insomnia (difficulty in sleeping)
- Chills
- Cough
- Bone pain
- Muscle spasm
- Dizziness
- Vascular occlusion
- Injection site irritation
- Stomatitis (Inflammation of the mouth)
- Weight loss
- Decreased white blood cell count (lymphocytes)
- Increased glucose level in blood
- Blood clot in the blood vessels
How to use Erytrust 2000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Erytrust 2000IU Injection works:
Erythropoietin injection, Erytrust 2000IU, boosts red blood cell production. This medication, an erythropoiesis stimulator, acts by prompting increased red blood cell generation within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erytrust 2000IU Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Erytrust 2000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Erytrust 2000IU Injection while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Erytrust 2000IU Injection may result in adverse reactions that could impair driving capabilities.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Erythropoietin (2000 IU) injection is considered safe. No alteration in dosage is necessary. However, routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with hepatic impairment should use Erytrust 2000IU Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Erytrust 2000IU Injection :
Should you forget a scheduled Erytrust 2000IU Injection, seek your physician's advice.
Facts to Know About Erytrust 2000IU Injection
Label | Value |
---|---|
Chemical Category | Amino Acid and Peptide Analogs |
Developing Habits | No. |
Treatment Category | KINSHIP |